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Recently, three subtypes of Borrelia burgdoiferi have been 
identified: Borrelia burgdoiferi sensu stricto, Borrelia garinii, 
and the VS 461 group of Borrelia burgdorferi. These subtypes 
differ by nucleotide sequence variations within several Borre-
lia burgdoiferi specific genes and most likely by their pathoge-
netic potential. To assess whether different subtypes of Borre-
lia burgdorferi might be associated with different cutaneous 
manifestations and clinial courses of Lyme disease, lesional 
skin biopsies from 35 patients with erythema migrans and 18 
patients with acrodermatitis chronica atrophicans were ana-
lyzed. A Borrelia burgdoiferi specific gene segment encoding a 
26-kD protein with subtype specific nucleotide sequence 
variations was amplified by a nested polymerase chain re-
action technique. For molecular subtyping, the products 
were transcribed into complementary RNA. Upon polyacryl-
amide gel electrophoresis, complementary RNA molecules 
E rythema migrans (EM) and acrodermatitis chronica atrophicans (ACA) represent cutaneous manifestations of an infection by Borrelia burgdoiferi (Bb), the causative agent of Lyme disease (LD) . Whereas ACA, a late mani-festation ofLD, is rarely found in the USA, EM, which 
occurs in the early course ofborreliosis, is prevalent both in Europe 
and the USA [1 ,2]. Based on whole DNA hybridization techniques, 
recently three subtypes of Bb were identified: Bb sensu stricto, Borre-
iia garinii, and the VS 461 group of Bb [3,4] . These subtypes differ by 
the nucleotide sequence of several chromosomal (flagellin, 16S 
rRNA) [5-7] and plasmid genes (Osp A, Osp B) [8,9] of Bb. In 
addition, a chromosomal gene of Bb [10,11] encoding for a 26-kD 
protein [12] was identified and nucleotide sequence variations 
within this gene were shown to correspond to known subtypes of Bb 
[13]. The prevalence of different subtypes of Bb in Europe and in the 
USA might explain the variations in the incidence of ACA and EM 
in these continents [3,4,8,14,15]. 
Until recently, subtyping of Bb in clinical specimens was depen-
dent on isolation and culture of Bb, which is time consuming and 
frequently unsuccessful. Therefore, we developed a molecular ap-
proach that allows the detection and classification of Bb in clinical 
specimens without isolating the spirochete [16]. In addition, the 
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separate into several metastable conformational forms result-
ing in patterns of bands highly specific for the nucleotide 
sequence of the transcribed molecules. In biopsy specimens of 
erythema migrans, the VS 461 subtype was detected in 28 of 
35 and the Borrelia garinii subtype in six of 35 cases. In one of 
35 cases of erythema migrans Borrelia burgdoiferi sensu stricto 
as well as Borrelia ga rinii was detected. In contrast, in all 18 
biopsies of acrodermatitis chronica atrophicans, only the VS 
461 subtype was identified. This subtype is rarely found in 
the USA, where acrodermatitis chronica atrophicans is al-
most unknown. These data indicate that acrodermatitis 
chronica atrophicans might be closely associated with the VS 
461 group of Borrelia burgdoiferi. Key words: Borrelia burg-
doiferi/Lyme disease/erythema migrans/acrodermatitis chronica 
atrophicans/polymerase chain reaction.] Invest Dermatol1 03: 19-
22, 1994 
assay can be performed on formalin-fixed, paraffin-embedded spec-
imens. 
In this assay nucleotide sequence differences within the gene 
encoding for the 26-kD protein are identified by PCR amplification 
of a 92 base pair (bp) fragment of this gene followed by transcription 
of the product into complementary RNA (cRNA) and subsequent 
analysis by non-denaturing polyacrylamide gel electrophoresis 
(PAGE) . Upon non-denaturing PAGE, cRNA molecules separate 
into several metastable conformational forms. These conforma-
tional polymorphisms strictly depend on the nucleotide sequence of 
the individual molecule. Analysis of single-strand conformational 
polymorphisms (SSCP) of cRNA molecules therefore represents a 
rapid and sensitive tool for identification of individual nucleotide 
sequence differences within PCR-amplified gene segments. This 
approach has been successfully applied to the detection of point 
mutations [17] and the subtyping of microorganisms [16] as well as 
to the identification of molecular marker sequences of cutaneous 
lymphomas [18]. In this study, molecular sub typing of Bb was per-
formed in lesions of35 patients with EM and 18 patients with ACA 
to determine whether different subtypes of Bb might be present in 
these skin manifestations of LD. 
MATERIALS AND METHODS 
Specimens Biopsy specimens of 49 patients with EM (29 fresh-frozen, 
cryoconserved; 20 formalin-fixed, paraffin-embedded) and of 33 patients 
with ACA (five fresh-frozen, cryoconserved; 28 formalin-fixed, paraffin-
embedded) were obtained at the Department of Dermatology of the Lud-
wig-Maximilians-University of Munich. Diagnoses were based on clinical 
history and appearance of the lesions (EM, edematous, erythematous plaque 
with centrifugal growth; ACA, atrophic, thin and shrivelled skin with tc-
leangiectasis and pigmentary changes) and on histomorphologic assessment 
of the biopsy specimens revealing features indicative or at lcast consistent 
with EM (nomlal epidermis, superficial and deep perivascular lymphocytic 
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infiltrate with plasma cells) or ACA (atrophic epidermis, swelling and ho-
mogenization of collagen fibers, loss of elastic fibers). In addition, in a subset 
of patients, IgM and IgG serum antibodies to Bb were obtained to substan-
tiate the diagnosis of a borrelial infection. Only those specimens in which 
Bb-specific DNA was amplified by polymerase chain reaction (PCR) were 
used for further analysis and molecular subtyping (see Results). As negative 
controls, 10 fresh-frozen and seven formalin-fixed biopsy specimens of pa-
tients with skin lesions not associated with Bb (lupus erythematosus, acne, 
granuloma annulare), as well as one formalin-fixed specimen of normal skin, 
were used. 
Serologic Tests IgM and IgG serum antibodies to Bb were evaluated by 
an indirect immunofluorescence assay. The sera were preabsorbed for 
"cross-reactive" antibodies with a Treponema phagedwis ultrasonicate. IgM or 
IgG antibody titers at least 1 : 10 were regarded as being elevated [19]. The 
results were confirmed by a Bb flagellum enzyme-linked immunosorbent 
assay [20J. 
DNA Isolation Fresh-frozen biopsies were cut into small pieces with 
disposable razor blades and transferred into 1.65-ml microcentrifuge tubes 
with 100 ttl of digestion buffer (0.2 M TrisCI, pH 8; 10 rnM ethylenedia-
minetetraacetic acid (EDTA); 1 % sodium dodecylsulfate) to which Protein-
ase K (Boehringer, Mannheim) was added to a final concentration of 1 
mg/m!. After incubation at 55'C for 2 d, DNA was extracted by phenolj 
chloroform, ethanol preciptated and redissolved in 100 ttl of des tilled and 
autoclaved water. 
DNA isolation from formalin-fixed, paraffin-embedded tissue was per-
formed as described [211. Briefly, ten 15-/lm- thick sections were cut from 
each block. To avoid cross contamination, the blade of the microtome was 
changed between samples. The sections were deparaffinized by xylene, pel-
leted by centrifugation, resuspended in digestion buffer with Proteinase K, 
and further processed as described above for the material obtained from 
fresh-frozen tissue. 
PCR Amplification PCR amplification of a fragment of a Bb-specific 
chromosomal gene segment encoding for a 26-kD protein was performed 
using a nested PCR technique as previously described [22] . Briefly, oligonu-
cleotide primers were designed to be complementary to regions conserved 
between the strain B31 (Bb sensu stricto) and the strain G2 (Borrelia garinii). 
First, a 171-bp fragment was amplified by an outer primer pair Bb-l and 
Bb-2. Ten microliters of the DNA solution of each sample was used as 
template for PCR amplification reactions in a final volume of 50 /ll contain-
ing 50 rnM KCI, 10 rnM TrisCI, 1.6 rnM MgCI, 200 /lM of each desoxyri-
bonucleotide triphosphate (dATP, dCTP, dGTP, dTTP), 0.5 units ofTaq 
DNA polymerase (Boehringer, Mannheim) and 25 pmol of each primer. 
The reaction mixtures were overlaid with 50 ttl of mineral oil to prevent 
evaporation and condensation. After initial denaturation at 95 ' C for 5 min, 
30 cycles of PCR were performed in a programmable heat block (Perkin 
Elmer Cetus) at 95'C for 1 min, 50 ' C for 1 min, and 72'C for 1 min. 
Subsequently, 0.5 ttl of the product was used as template in a second PCR 
reaction using conditions as described above with the inner primer pair 
T7 -Bb-3 and Bb-4. These primers amplify a 92-bp segment of the Bb-specific 
gene. The T7-RNA polymerase promoter sequence was added to the 5' end 
of the T7 -Bb-3 primer to facilitate subsequent transcription of the PCR 
products into cRNA. Ten microliters of the nnal product was analyzed by 
agarose gel electrophoresis (2.5% agarose in Tris-Borate-EDTA) and visu-
al ized by ultraviolet radiation after ethidium bromide staining. 
Previous experiments demonstrated that PCR amplification using the 
primers T7 -Bb3 and Bb-4 with DNA from cultured strains of spirochetes not 
related to LD (Borrelia nermsii, Borrelia parkeri, Borrelia tUTicatae, Treponema 
pallidum, and TrepotJema delltito/a) does not result in an appropriate PCR 
product. In contrast, DNA of cultured strains of Bb (B31, IP1, Z25, Z37, 
ECM1, ACA1, B023, Dpi, N34, 20047, Ho14, and 13 additional Bb strains 
isolated from EM lesions or ticks) was amplified and a subtype-specific 
pattern of bands representing conformational polymorphisms of cRNA 
molecules was obtained for each Bb subtype and confirmed by direct nucleo-
tide sequence analysis [13]. These patterns from characterized strains of Bb 
were used as standard patterns in the present study. Primer sequences were 
(T7 promoter sequence underlined) for Bb-1, AAAACGAAGATACTC-
GATCTGTAATTGC; for Bb-2, TTGCAGAATTTGATAAAGTTGG; 
for T7-Bb-3, TAATACGACTCACTATAGGGAGATCTGTAATTGC-
AGAAACACCT; and for Bb-4, GAGTATGCTATTGATGAATTATTG. 
In Vitro Transcription Three microliters of the PCR product were tran-
scribed into cRNA by 30 units of T7-RNA-polymerase (Pharmacia) in a 
reaction volume of25 J.d. The transcription buffer contained 40 rnM TrisCI, 
pH 7.5; 12 rnM MgCI2 ; 10 rnM dithiothreitol; 10 mMspermidine; 1 rnMof 
each ribonucleotide ATP, CTP, GTP, and UTP; and 7.5 units of RNA 
guard (Pharmacia). The mixture was incubated for 2 h at 37'C. To stop the 
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reaction 7.5/ll of a stop solution (50% glycerol, 0.033% bromphenol blue, 
50 rnM NaEDTA, pH 8.0) was added. 
Analysis of Conformational Polymorphisms of cRNA After heating 
to 65'C for 6 min, samples were chilled on ice and 15/ll of the cRNA 
mixture was loaded onto a 10% polyacrylamide gel with 10% glycerol. 
Analysis was performed in a Hoeffer 650 dual cooled page unit cooled with 
tap water at 16'C. The gel dimensions were 130 X 180 X 1.5 mm. Gels 
were run at 50 V during the first hour and at 500 V for three additional 
hours. After completion of electrophoresis, the wet gel was stained with 
ethidium bromide and photographed with Polaroid 677 film (13). 
RESULTS 
Detection of Borrelia burgdorferi In fresh-frozen, cryocon-
served specimens Bb-specific DNA was detected by PCR in 26 of29 
cases of EM and in all five cases of ACA. All 10 biopsy specimens of 
lesions not associated with LD were negative. 
In formalin-fixed, paraffin-embedded tissue samples Bb-specific 
DNA was detected in nine of 20 specimens of patients with EM and 
in 13 of28 specimens of patients with ACA. All seven specimens of 
lesions not related to LD, as well as the formalin-fixed specimen of 
normal skin, were negative. In total, Bb-specifi.c DNA was detected 
by PCR in 35 lesions of EM and 18 lesions of ACA (Table I). These 
samples were used for further analysis and molecular subtyping of 
Bb. The accuracy of diagnoses in these patients was substantiated 
by elevated IgM and/or IgG antibody titers to Bb in the majority 
of tested patients with EM and in all tested patients with ACA 
(Table I). 
Molecular Subtyping of Bb The PCR products were tran-
scribed into cRNA followed by polyacrylamide gel electrophoresis 
for assessment of conformational polymorphisms. Patterns obtained 
from the clinical samples were compared with standard patterns 
from the characterized cultured strains of Bb. In 35 lesions of EM, 
the VS 461 group of Bb was identified in 28 (80%) and Borrelia 
garinii in six (17%) cases. In one sample both Borrelia ga rinii and Bb 
sensu stricto were detected as previously reported [23]' In all 18 
lesions of ACA only the VS 461 group of Bb was identified (Fig 1). 
DISCUSSION 
The system presented in this study allows the rapid molecular de-
tection and subtyping of Bb in skin biopsies of patients with LD. 
Bb-specific DNA sequences were successfully detected and charac-
terized in nearly all fresh-frozen, cryoconserved biopsy specimens 
of patients with EM and ACA. This high percentage of PCR-posi-
tive cases indicates that the majority of possible Bb subtypes asso-
ciated with skin manifestations ofLD will be detected by the system 
used. The lower percentage of PCR-positive cases in formalin-
fixed, paraffin-embedded material is most likely due to technical 
limitations, as formalin-fixation and long-term storage in paraffin 
may cause extensive degradation of DNA. However, in cases where 
Bb- specific DNA sequences can be amplified by PCR from paraf-
fin-embedded material, subtyping can be rapidly and accurately per-
formed using the cRNA-based assay. 
In comparison to the analysis ofPCR-amplified gene segments by 
oligonucleotide hybridization or restriction enzyme digestion tech-
niques, the system presented using conformational polymorphisms 
of eRN A molecules has the advantage that also novel and so far 
uncharacterized nucleotide sequence variations will be detected 
with high sensitivity. In several studies, the eRN A-based assay has 
proved to be able to precisely recognize even single nucleotide sub-
stitutions in analyzed gene segments [13,16,17,23]. Recently, we 
identified a novel and so far uncharacterized nucleotide sequence 
variation within the VS 461 group of Bb by cRNA-SSCP and subse-
quent confirmation by direct nucleotide sequence analysis [13,16]. 
Prior to the molecular analysis as presented in this study, subtyp-
ing of Bb in patients with LD has been performed by Western blot 
analyses of sera from LD patients using various borrelial strains as 
antigens [24]. Sera obtained from eight patients with ACA prefer-
entially reacted with blotted proteins of the VS 461 group of Bb. 
However, serotyping of Bb is an indirect technique that depends on 
the patients immune response and that may not be equally detecta-
VOL. · 103, NO.1 JULY 1994 MOLECULAR SUBTYPING OF BORREUA BURGDORFERI 21 
Table I. Characteristics of patients with erythema migrans (A) and acrodermatitis chronica atrophicans (B)a 
Serum Antibody Titers 
Fixation/Storage 
to Bb (IFA-ABS) ' 
Borrelia Burgdorferi 
Additional Symptoms of Biopsy! IgM IgG Subtyped 
A) Patients with erythema migrans 
1 cc 1: 5 1:5 a 
2 Radiculitis cc <1 :5 1 : 80 b 
3 Fever, multiple EM cc 1:40 <1 :5 b 
4 cc ND ND a 
5 Arthralgia cc 1:5 <1 :5 a 
6 Fever cc <1 : 5 <1 :5 a 
7 Myalgia cc <1 :5 <1 :5 a 
8 Syncopes cc ND' ND a 
9 cc 1: 20 1:5 b 
10 Myalgia, arthralgia cc 1:40 1 : 20 a 
11 Headache cc <1 :5 1:20 a 
12 Myalgia cc 1:5 1:40 a 
13 cc 1 : 5 1:40 a 
14 cc <1 :5 1:20 a 
15 Meningoradiculitis cc <1:5 1 : 640 b 
16 cc 1: 5 1: 5 a 
17 cc <1 :5 1: 10 
18 cc <1 :5 1:80 a 
19 cc 1:20 < 1 :5 a 
20 cc <1 :5 <1 :5 a 
21 cc ND ND b 
22 Bullous EM cc <1 :5 1:10 a 
23 cc <1 :5 < 1 : 5 a 
24 cc 1: 20 1:40 a 
25 If 1: 5 1:160 a 
26 If <1 :5 1 :40 a 
27 If 1: 20 1:20 a 
28 If 1:10 1: 1280 band c 
29 Meningoradiculitis If 1:160 1:80 a 
30 If < 1 :5 < 1 : 5 a 
31 Fatigue If 1 : 40 1 : 80 a 
32 Fatigue If 1: 10 1 : 160 a 
33 If ND ND b 
34 Headache cc <1 :5 < 1 : 5 a 
35 cc 1 :20 1: 5 a 
B) Patients with acrodermatitis chronica atrophicans 
1 cc < 1 : 5 1 :640 a 
2 cc < 1 :5 1:320 a 
3 cc ND ND a 
4 Periarticular fibrous nodules cc < 1 : 5 1: 1280 a 
5 Arthralgia cc 1:10 1:10 a 
6 Arthralgia, myalgia, headache If < 1 :5 1:160 a 
7 Periarticular fibrous nodules If 1: 5 1:1280 a 
8 If <1 :5 1:160 a 
9 If < 1 :5 1:320 a 
10 If < 1 :5 1:320 a 
11 If 1:80 1: 40 a 
12 If ND ND a 
13 If ND ND a 
14 If <1 : 5 1:80 a 
15 If < 1 :5 1:640 a 
16 If ND ND a 
17 If <1 : 5 1:640 a 
18 Arrhythmia If <1 :5 1 : 320 a 
• In biopsy specimens of these patients Bb-specific DNA was detected by PCR. Molecular subtyping of Bb was performed by analysis of cRNA-single-strand conformationa.l 
polymorph isms (cRNA-SSCP) of a peR amplified segment of a Bb-specific gene with subtype specific nucleotide sequence variations. 
I cc, fresh-frozen, ctyo-conserved; ff, formalin-fixed, paraffin-embedded. 
, Indirect immunofluorescence assay after preabsorption of the sera with Treponema phagedenis. Cutoff value for a positive test: titers at leas t I : 10. 
, a, VS 461 group of Borrelia bllrgdorJeri; b, Borrelia garinii; c, Borrelia bllrgdorferi sensu stricto. 
, NO, not done. 
ble and specific in all cases during the course of the disease. Further-
more, retrospective studies on cases with only formalin-fixed, par-
affin-embedded biopsy material available are not possible. In 
another study using a classification system for Bb based on the reac-
tivity of monoclonal antibodies for OspA with cultured strains of 
Bb, 10 of 11 strains originally isolated from ACA lesions were 
classified as the VS 461 group of Bb [14]. 
The observation of an association of the VS 461 subtype of Bb 
with ACA might explain the exceedingly low incidence of ACA in 
the USA as compared to the considerably higher number of cases of 
ACA in Europe [1,2]. In the USA Bb strains isolated from skin 
biopsies of patients with LD as well as other sources, e.g., ticks or 
cerebrospinal fluid, so far all belong to the Bb sensu stricto group, 
whereas three subtypes of Bb including the VS 461 group are 
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1 2 3 4 5 6 7 8 9 10 11 
Figure 1. Representative examples of molecular subtyping of Bb in speci-
mens of patients with EM (lanes 1-5) and ACA (lanes 6 - 9) . A segment of a 
Bb-specific gene with subtype-specific nucleotide sequence variations was 
amplified by PCR. Molecular subtyping was performed by analysis of 
cRNA-single-strand conformational polymorphisms (cRNA-SSCP) of the 
amplified gene segment by PAGE. Lane 10: standard pattern obtained from 
cultured strain ECM 1 (VS 461 subgroup of Bb). Lane 11: standard pattern 
obtained from cultured strain N34 (Borrelia $.ari",·i). In biopsy specimens of 
patients with EM the Borrelia gnTinji subtype (lan es 1 - 2) or the VS 461 group 
ofBb (lanes 3-5) was detected. In all biopsy specimens of patients withACA 
only the VS 461 group of Bb was detected (folies 6 - 9). 
present in Europe [3,4,8,14,15]. Further studies using rapid and 
sensitive assays such as the cRNA-SSCP method presented here will 
help to clarify further associations of specific subtypes of Bb with 
distinct clinical courses of LD, e.g., arthritis or meningoencephali-
tis. They may playa future role in the rational management and 
follow up of patients with LD, as subgroups of patients with risks for 
specific long-term complications ofLD such as ACA can be identi-
fied. 
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